Abstract:
The invention provides a composition comprising a strain of a bacteria for use in the treatment or prevention of a Gram-positive bacterial infection in a subject, wherein the strain produces valeric acid.
Abstract:
The invention provides compositions comprising bacterial strains for use as a vaccine adjuvant; for use in treating, preventing or delaying immunosenescence; or for use in enhancing a cell therapy, such as CAR-T. The invention also provides vaccine compositions comprising bacterial strains and one or more antigens.
Abstract:
Provided are compositions comprising a bacterial strain of the genus Bacteroides, for use in a method of increasing the microbiota diversity and/or inducing stability of the microbiota of a subject.
Abstract:
The invention provides a composition comprising a bacterial strain of the genus Megasphaera , for use in stimulating the immune system in subject.
Abstract:
Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis im perfecta.
Abstract:
Theinvention relates to oligonucleotides suitable for use in treating human disease. More in particular the inventionrelates to antisense oligonucleotides suitable for the treatment of Alzheimer's disease.
Abstract:
A method for detecting the presence of an enzyme in a composition. The method involves incubating the composition with a pro-ligand, a proto-catalyst and a substrate. Any enzyme present can cause conversion of the pro-ligand to a ligand. The ligand can activate the proto-catalyst to provide an active catalyst. The active catalyst can cause conversion of the substrate to a detectable product and the detectable product may be detected distinguishably from the substrate. The presence of enzyme is detected by detecting the detectable product. The method may be used to detect the presence of an analyte in a composition.